NASDAQ:ADRO
Delisted
Aduro Biotech Stock News
$14.60
+0 (+0%)
At Close: May 27, 2022
Proteostasis (PTI) to Report Q4 Earnings: What's in Store?
02:56pm, Wednesday, 26'th Feb 2020
We expect Proteostasis Therapeutics (PTI) to provide updates on its pipeline when its releases fourth-quarter 2019 results.
What in Store for Universal Health's (UHS) Q4 Earnings?
03:36pm, Tuesday, 25'th Feb 2020
Universal Health's (UHS) Q4 results are likely to reflect gains from both its Acute Care and Behavioral Health segments.
NuCana (NCNA) to Report Q4 Earnings: What's in the Cards?
02:46pm, Tuesday, 25'th Feb 2020
We expect NuCana (NCNA) to provide updates on its pipeline when it releases fourth-quarter results.
NuCana (NCNA) to Report Q4 Earnings: What's in the Cards?
02:46pm, Tuesday, 25'th Feb 2020
We expect NuCana (NCNA) to provide updates on its pipeline when it releases fourth-quarter results.
Epizyme (EPZM) Q4 Earnings Miss Estimates, Revenues Beat
02:38pm, Tuesday, 25'th Feb 2020
Epizyme (EPZM) reports wider-than-expected loss in the fourth quarter of 2019. Nonetheless, its sales beat estimates.
Aduro Biotech to Present at the Cowen and Company 40th Annual Health Care Conference
09:15pm, Monday, 24'th Feb 2020
BERKELEY, Calif., Feb. 24, 2020 -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is.
Is a Beat in Store for Perrigo (PRGO) This Earnings Season?
02:27pm, Monday, 24'th Feb 2020
Perrigo's (PRGO) Consumer Self Care Americas segment is expected to have aided the company's top line in the soon-to-be-reported quarter.
Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
02:02pm, Monday, 24'th Feb 2020
Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.
Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
02:02pm, Monday, 24'th Feb 2020
Investors will focus on Cronos' (CRON) regular top- and bottom-line numbers, along with its pipeline progress, when it reports Q4 results.
Aduro Biotech to Present at the 9th Annual SVB Leerink Global Healthcare Conference
01:15pm, Wednesday, 19'th Feb 2020
BERKELEY, Calif., Feb. 19, 2020 -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is.
What's in Store for Select Medical's (SEM) Q4 Earnings?
03:10pm, Tuesday, 18'th Feb 2020
Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.
What's in Store for Select Medical's (SEM) Q4 Earnings?
03:10pm, Tuesday, 18'th Feb 2020
Select Medical's (SEM) Q4 results are likely to reflect revenue growth across all its segments, increase in expenses and share buyback.
Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Aduro BioTech (ADRO)
01:11pm, Friday, 07'th Feb 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alnylam Pharma (ALNY) and Aduro BioTech (ADRO) with bullish
Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Aduro BioTech (ADRO)
01:11pm, Friday, 07'th Feb 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alnylam Pharma (
ALNY
–
Research Report
) and Aduro BioTech (
ADRO
–
Research Report
) with bullish
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N